Polymorphism (-499C/G) in DDAH2 promoter may act as a protective factor for metabolic syndrome: A case-control study in Azar-Cohort population

OBJECTIVE: Globally developing metabolic syndrome (MetS) prevalence as a major health problem can be related to multiple factors of genetic and environmental. Dimethylaminohydrolase 2 (DDAH2) is the main enzyme implicated in the cardiovascular system, which regulates the nitric oxide pathway. This s...

Descripción completa

Detalles Bibliográficos
Autores principales: Faramarzi, Elnaz, Aftabi, Younes, Ansarin, Khalil, Somi, Mohammad Hossein, Gilani, Neda, Seyedrezazadeh, Ensiyeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Endocrinologia e Metabologia 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522192/
https://www.ncbi.nlm.nih.gov/pubmed/34283907
http://dx.doi.org/10.20945/2359-3997000000391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522192/
https://www.ncbi.nlm.nih.gov/pubmed/34283907
http://dx.doi.org/10.20945/2359-3997000000391

Ejemplares similares